Who Owns AEON Biopharma Stock?
NYSE: AEONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.2876 +4.20%
Ownership breakdown
- Held by institutions
- 32.77%
- Held by insiders
- 54.98%
- Institutional holders
- 27
- Institutions 32.8%
- Insiders 55.0%
- Public and other 12.2%
Who owns AEON Biopharma stock?
Institutional investors own about 32.8% of AEON Biopharma's shares, spread across 27 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 54.98% of AEON.
The largest institutional holders are Dauntless Investment Group, LLC (25.04%), Geode Capital Management, LLC (0.19%) and Vanguard Capital Management LLC (0.18%). Together, the top 10 institutions control 25.7% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their AEON positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AEON
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Dauntless Investment Group, LLC | 12.49M | 25.04% | +394.1% |
| Geode Capital Management, LLC | 95.31K | 0.19% | +9.5% |
| Vanguard Capital Management LLC | 90.53K | 0.18% | 0.0% |
| Blue Owl Capital Holdings LP | 42.35K | 0.08% | 0.0% |
| Formidable Asset Management, Llc | 20.02K | 0.04% | 0.0% |
| Stonex Group Inc. | 18.95K | 0.04% | +100.0% |
| Vanguard Fiduciary Trust Co | 13.71K | 0.03% | -6.7% |
| Beacon Wealthcare, LLC | 12.86K | 0.03% | +100.0% |
| LPL Financial LLC | 11.51K | 0.02% | 0.0% |
| Citigroup Inc. | 7.32K | 0.01% | +885.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AEON
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 90.53K | 0.18% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 55.78K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 11.19K | 0.02% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 3.07K | 0.01% |
Frequently asked questions
Who is the largest shareholder of AEON Biopharma?
Dauntless Investment Group, LLC is the largest institutional shareholder of AEON, owning 25.04% of shares outstanding (12.49M shares) as of its latest 13F filing.
What percentage of AEON Biopharma is owned by institutions?
Institutions own about 32.8% of AEON shares and 72.8% of the public float.
How much of AEON Biopharma do insiders own?
Insiders, such as officers and directors, own about 54.98% of AEON shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.